Medical policy
Journey to LCD coverage
Learn how the local coverage determination (LCDs) process works with this informative guide. General information on the local coverage development (LCD) process.
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
Proposed local coverage determinations (LCDs): Open meetings
Open meeting registration is currently not available. Registration will open approximately two weeks prior to the next meeting. Please watch here for meeting details and registration for the next…
Proposed local coverage determinations (LCDs): Open meetings
Open meeting registration is currently not available. Registration will open approximately two weeks prior to the next meeting. Please watch here for meeting details and registration for the next…
Drugs and biologicals: Self-administered drug exclusions
Self-administered drugs
Self-Administered Drug Exclusion List (A52571)
Drugs and biologicals: Self-administered drug exclusions
Self-administered drugs
Self-Administered Drug Exclusion List (A52571)
Multi-jurisdictional contractor advisory committee (CAC) meeting minutes
Multi-jurisdictional CAC meeting minutes